Prague Med. Rep. 2022, 123, 243-249
https://doi.org/10.14712/23362936.2022.22
Malignancy Rates in Thyroid Nodules Classified as Bethesda III and IV; Correlating Fine Needle Aspiration Cytology with Histopathology
References
1. , E. K., Kennedy, G. C., Baloch, Z. W., Cibas, E. S., Chudova, D., Diggans, J., Friedman, L., Kloos, R. T., LiVolsi, V. A., Mandel, S. J., Raab, S. S., Rosai, J., Steward, D. L., Walsh, P. S., Wilde, J. I., Zeiger, M. A., Lanman, R. B., Haugen, B. R. (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N. Engl. J. Med. 367(8), 705–715.
<https://doi.org/10.1056/NEJMoa1203208>
2. , S., Gunes, P., Onenerk, M., Erkan, M., Kilinc, E., Gursan, N. K., Kilicoglu, G. Z. (2016) New concept of the encapsulated follicular variant of papillary thyroid carcinoma and its impact on the Bethesda system for reporting thyroid cytopathology: A single-institute experience. Acta Cytol. 60(3), 198–204.
<https://doi.org/10.1159/000447990>
3. , B. G., Leite, A. K. N., de Matos, L. L., Miazaki, A. P., Ientile, J. M., Kulcsar, M. A. V., Cernea, C. R. (2018) Malignancy rates in thyroid nodules classified as Bethesda categories III and IV: Retrospective data from a tertiary center. Int. J. Endocrinol. Metab. 16(1), e12871.
4. , S. R., Pavithran, P. V., Abraham, N., Nair, V., Bhavani, N., Kumar, H., Menon, U. V., Menon, A. S. (2019) Prospective study of Bethesda categories III and IV thyroid nodules: Outcomes and predictive value of BRAFV600E mutation. Indian J. Endocrinol. Metab. 23(3), 278–281.
5. , E. S., Ali, S. Z. (2017) The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 27(11), 1341–1346.
<https://doi.org/10.1089/thy.2017.0500>
6. , A., Linder, A., Hameed, O., Salih, C., Roberson, J., Gidley, J., Eltoum, I. A. (2011) The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, “risk” of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions. Cancer Cytopathol. 119(5), 315–321.
<https://doi.org/10.1002/cncy.20174>
7. , A. S., Sarti, E. E., Jain, K. S., Wang, H., Nixon, I. J., Shaha, A. R., Shah, J. P., Kraus, D. H., Ghossein, R., Fish, S. A., Wong, R. J., Lin, O., Morris, L. G. (2014) Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 24(5), 832–839.
<https://doi.org/10.1089/thy.2013.0317>
8. , V. Y., Stelow, E. B., Dustin, S. M., Hanley, K. Z. (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 134(3), 450–456.
<https://doi.org/10.1309/AJCP5N4MTHPAFXFB>
9. , A., Najafian, A., Schneider, E. B., Zeiger, M. A., Olson, M. T. (2014) Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology. Surgery 156(6), 1471–1476.
<https://doi.org/10.1016/j.surg.2014.08.026>
10. , N. P., Nikiforova, M. N., Schoedel, K. E., LeBeau, S. O., Hodak, S. P., Seethala, R. R., Carty, S. E., Ogilvie, J. B., Yip, L., Nikiforov, Y. E. (2010) Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”. Cancer Cytopathol. 118(1), 17–23.
<https://doi.org/10.1002/cncy.20063>
11. , R., Yoder, B. J., Massoll, N. A. (2006) Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: A survey of clinicians and pathologists. Thyroid 16(10), 1003–1008.
<https://doi.org/10.1089/thy.2006.16.1003>
12. , Y., Ding, X., Klein, M., Sugrue, C., Matano, S., Edelman, M., Wasserman, P. (2009) Thyroid fine-needle aspiration with atypia of undetermined significance: A necessary or optional category? Cancer Cytopathol. 117(5), 298–304.
<https://doi.org/10.1002/cncy.20039>
13. , J., Schlecht, N. F., Fink, D., Khader, S. N., Smith, R. V., Cajigas, A. (2010) Thyroid fine needle aspiration cytology: Follicular lesions and the gray zone. Acta Cytol. 54(2), 123–131.
<https://doi.org/10.1159/000324996>
14. Bayrak, B., Eruyar, A. T. (2020) Malignancy rates for Bethesda III and IV thyroid nodules: A retrospective study of the correlation between fine-needle aspiration cytology and histopathology. BMC Endocr. Disord. 20(1), 1–9.
